Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Posted on by Pencis

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award 

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

  • Dean of the Experimental Animal Center 🐁
  • Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

  • Cross-organ communication in cardiovascular and metabolic diseases
  • Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
  • Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Christopher Coe | Cardiovascular Researches | Best Research Article Award

Posted on by Pencis

Prof. Christopher Coe | Cardiovascular Researches | Best Research Article Award

Prof. Christopher Coe, University of Wisconsin-Madison, United States

Prof. Christopher Coe is a distinguished professor emeritus in psychology at the University of Wisconsin-Madison, recognized for his pioneering work in psychoneuroimmunology and developmental psychobiology. With a career spanning leading institutions, he has made significant contributions to understanding the interaction of stress, immune function, and social behavior, earning numerous accolades for his research and teaching.

Author Profile:

Scopus Profile

Orcid Profile

Educational Details:

Prof. Christopher Coe, Professor Emeritus at the University of Wisconsin-Madison, is a distinguished expert in biological psychology and psychoneuroimmunology. He earned a B.A. in Anthropology (cum laude) with a minor in Biology from City College, City University of New York, in 1971, and a Ph.D. in Biological Psychology from Downstate Medical Center, SUNY, in 1976. Following this, he completed a postdoctoral fellowship in developmental psychobiology at Stanford University Medical School (1976-77). Prof. Coe’s career has been marked by groundbreaking research on the interplay between behavior, stress, and immune function, as well as exceptional contributions to teaching and academic leadership.

Professional Experience:

Prof. Christopher Coe has had an illustrious academic career spanning over five decades, beginning as a Lecturer at the American Museum of Natural History in New York (1970-71). He held key roles at Stanford University, including Postdoctoral Fellow (1976-77), Assistant Director of the Outdoor Primate Facility (1977-79), and Assistant Professor at the School of Medicine (1981-85). Joining the University of Wisconsin-Madison in 1985, he served as Associate Professor, Director of the Harlow Center for Biological Psychology, and later as Professor (1988-2022). Honored as the W.B. Cannon Professor of Biopsychology (2001-2022), he is now Professor Emeritus and Honorary Scholar.

Research Interests:

Prof. Christopher Coe’s research spans developmental psychobiology, psychoneuroimmunology, and sociophysiology. He investigates how early life experiences shape biological and psychological development, the interplay between stress, behavior, and immune system function, and the biological basis of social interactions and their effects on health and well-being.

Research Skills:

Prof. Christopher Coe specializes in designing and conducting longitudinal studies in developmental psychobiology, with expertise in psychoneuroimmunology and animal behavioral research. He is also proficient in sociophysiological measurement techniques and advanced data analysis, enabling a comprehensive understanding of the biological and behavioral dynamics underlying health and development.

Research Projects:

Prof. Christopher Coe has spearheaded pioneering research projects on the impact of stress and early life experiences on immune development, behavioral and physiological adaptations in primates, and the psychosocial factors influencing health and resilience throughout the lifespan.

Awards and Honors:

Prof. Christopher Coe has received numerous prestigious awards, including the Chancellor’s Award for Excellence in Teaching (1997), the WARF Professorship as W.B. Cannon Professor (2001), and the Norman Cousins Award for Psychoneuroimmunology Research (2001). Other honors include the Ziskind-Somerfield Award for Innovative Research (2004), the Hilldale Award for Teaching and Scholarship (2006), the P. Barchas Award for Sociophysiology Research (2008), and an Honorary Professorship from South China Normal University (2009). He also earned the Best Research in Health and Society accolade (2011) and the UW Board of Regents Teaching Excellence Award (2013).

Conclusion:

Prof. Christopher Coe’s career exemplifies excellence in academic leadership, innovative research, and impactful teaching. His contributions to psychology and biopsychology continue to inspire scholars and shape the understanding of health, behavior, and development.

Top Notable Publications:

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease

Authors: Hansen, J.L., Rumble, M.E., Coe, C.L., Hematti, P., Costanzo, E.S.

Year: 2025

Citations: 0

Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation

Authors: Bu, Y., Burks, J., Yang, K., Coleman, T.P., Lerman, I.

Year: 2024

Citations: 0

Higher inflammatory proteins predict future depressive symptom severity among adolescents with lower emotional clarity

Authors: Stephenson, A.R., Ka-Yi Chat, I., Bisgay, A.T., Abramson, L.Y., Alloy, L.B.

Year: 2024

Citations: 0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Authors: Turner, D.G.P., De Lange, W.J., Zhu, Y., Ralphe, J.C., Glukhov, A.V.

Year: 2024

Citations: 2

Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys

Authors: Coe, C.L., Nimityongskul, F., Lubach, G.R., Rancour, D., Schomburg, F.M.

Year: 2024

Citations: 0

Exercise does not cause post-exertional malaise in Veterans with Gulf War Illness: A randomized, controlled, dose–response, crossover study

Authors: Boruch, A.E., Barhorst, E.E., Rayne, T.J., Cook, D.B., Lindheimer, J.B.

Year: 2024

Citations: 1

Financial Hardship and Age-Related Decrements in Kidney Function among Black and White Adults in the Midlife in the United States Study

Authors: Surachman, A., Harhay, M., Santos, A.R., Almeida, D.M., Coe, C.L.

Year: 2024

Citations: 1

Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents

Authors: Wood, E.K., Reid, B.M., Sheerar, D.S., Gunnar, M.R., Coe, C.L.

Year: 2024

Citations: 1

Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency Induced Metabolic Brain Dysfunction in Infant Rhesus Monkeys

Authors: Sandri, B.J., Kim, J., Lubach, G.R., Coe, C.L., Rao, R.B.

Year: 2024

Citations: 3

The Impact of Early and Recent Life Stress on Trajectories of Inflammatory Biomarkers in a Diverse Sample of Adolescents

Authors: Kautz, M.M., McArthur, B.A., Moriarity, D.P., Abramson, L.Y., Alloy, L.B.

Year: 2023

Citations: 4

Fulin Liu | Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

🎓 Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

💼 Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

🥇Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

📚Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Introduction of HeartBeat Excellence Award

Posted on by Pencis

Introduction of HeartBeat Excellence Award

Welcome to the prestigious HeartBeat Excellence Award, celebrating outstanding contributions and innovation in the realm of cardiology and cardiovascular medicine. This esteemed award seeks to honor individuals who have demonstrated unparalleled excellence, pushing the boundaries of knowledge and making profound impacts on the cardiovascular field.

Award Eligibility: The HeartBeat Excellence Award is open to professionals, researchers, and practitioners in the field of cardiology worldwide. Eligible candidates include those who have significantly contributed to advancements in cardiovascular medicine, irrespective of age or affiliation.

Qualification and Publications: Candidates should possess a minimum of 5 years of experience in cardiology and should have made noteworthy contributions through research, publications, or innovative practices.

Evaluation Criteria: The award selection is based on the candidate’s demonstrated impact on the field, the originality of research, and the significance of contributions to cardiovascular science and medicine.

Submission Guidelines: Candidates are invited to submit a detailed biography, an abstract of their work, and supporting files showcasing their contributions to the field. Submissions should be made in accordance with the outlined guidelines on our official platform.

Recognition: Recipients of the HeartBeat Excellence Award will receive a prestigious trophy, a certificate of recognition, and widespread acknowledgment in the cardiovascular community.

Community Impact: This award not only celebrates individual achievements but also aims to inspire and uplift the entire cardiovascular community, fostering a culture of continuous innovation and excellence.

Biography, Abstract, and Supporting Files: The biography should highlight the candidate’s professional journey and contributions. The abstract should provide a succinct overview of the work, while supporting files should include relevant publications, research findings, or any other materials that showcase the impact of the candidate’s work.